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Visual  impairment  is  a global  public  health  problem  that needs  new  candidate  drugs.  Chrysanthemum  is
a  traditional  Chinese  drug,  famous  for its  eye-protective  function,  with  an  unclear  mechanism  of  action.
To determine  how  chrysanthemum  contributes  to  vision,  we identiﬁed,  for  the  ﬁrst  time,  the  component
of  chrysanthemum, diosmetin  (DIO),  which  acts in  protecting  the  injured  retina  in  an  adriamycin  (ADR)
improving  model.  We  observed  that DIO  could  attenuate  the  apoptosis  of  retinal  cells  in  Sprague–Dawley
rats  and  veriﬁed  this  effect  in cultured  human  retinal  pigment  epithelium  (RPE)  cells,  ARPE-19.  Our  further
study  on  the mechanism  revealed  the  counteractive  effect  of  DIO on the attenuation  of DNA damage  and
oxidative  stress,  which  occurs  in  a wide  range  of  retinal  disorders.  These  results  collectively  promise  the
potential  value  of DIO as a retinal-protective  agent  for disorders  that lead  to  blindness.  In addition,  we
identiﬁed,  for  the  ﬁrst time,  the  component  of  chrysanthemum, DIO,  which  acts  in  protecting  the  injuredpoptosis
hrysanthemum
iosmetin
NA damage
xidative stress
etinal injury
retina.
© 2016  Published  by  Elsevier  Ireland  Ltd.  This is an  open  access  article  under the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).etinal pigment epithelium
. Introduction
Recently, it was observed that there is a trend of people having a
reater risk of visual impairment as a result of aging, light pollution
nd greater propensity for visually disabling conditions. To address
he issue of decreased vision, more drugs that can improve eye-
ight need to be made available. Turning to Chinese medicine, the
hrysanthemum, cultivated in China as a ﬂowering herb dates back
o the 15th Century B.C [33] http://www.mums.org/history-of-the-
hrysanthemum/, December 10, 2014). It has long been prescribed
Abbreviations: ADR, adriamycin; AMD, age-related macular degeneration; ATP,
denosine triphosphate; CNV, choroidal neovascularisation; DIO, diosmetin; H&E,
ematoxylin and eosin; IC50, inhibition for 50% of the cells; IVI, intravitreal injec-
ion; PVR, proliferative vitreoretinopathy; ROS, reactive oxygen species; RPE, retinal
igment epithelium.
∗ Corresponding author at: Institute of Pharmacology & Toxicology, College of
harmaceutical Sciences, Zhejiang University, 866 Yuhangtang Road, Zijingang Cam-
us, Zhejiang University, Hangzhou, Zhejiang, P.R. China. Fax: +86 571 88208400.
E-mail address: peihualuo@zju.edu.cn (P. Luo).
1 These authors contributed equally to the manuscript.
ttp://dx.doi.org/10.1016/j.toxrep.2015.12.004
214-7500/© 2016 Published by Elsevier Ireland Ltd. This is an open access article under for the treatment of eye diseases in Chinese traditional prepara-
tions. Recent studies have shown that ﬂavonoids in chrysanthemum
are more likely to contribute to curing eye diseases [1,21,23,30,41].
Despite of recent progress, the deﬁnite component of chrysanthe-
mum and the mechanism of action in the way chrysanthemum
contributes to vision remains to be elucidated.
Diosmetin (3′,5,7-trihydroxy-4′-methoxyﬂavone) is the agly-
cone of the ﬂavonoid glycoside diosmetin-7-O--d-glucoside,
which occurs naturally in the chrysanthemum ﬂower heads. This
glucoside is hydrolyzed to its aglycone diosmetin (DIO) by intesti-
nal microﬂora enzymes prior to its absorption into the body.
Pharmacologically, it has been established that DIO possesses
strong antioxidant properties [7,25,50]. In addition, the latest study
demonstrated that DIO could signiﬁcantly enhance the adenosine
triphosphate (ATP) levels in cells [36]. Because many retinal dis-
eases are related to excessive oxidant stress and limited ATP release
[3,14,26,35,38], we  hypothesized that DIO is the key factor by which
chrysanthemum improves eye function based on the analysis of its
protective effect related to its potent antioxidant and increased ATP
in the retina.
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Adriamycin (ADR), also called doxorubicin, is an antibiotic
nthracycline that is widely applied in ophthalmology against sev-
ral proliferative and angiogenic eye diseases, such as proliferative
itreoretinopathy (PVR) [32], choroidal neovascularization (CNV)
46] and some ocular tumors [18,34], because of its anti-angiogenic
nd anti-proliferative properties. However, the efﬁcacy of ADR for
ye diseases is limited by its toxic retinal effects [13,46] at two
undamental levels, altering DNA and producing free radicals [11].
hese events are observed in many potentially blinding eye condi-
ions, such as AMD  [3,22], diabetic retinopathy [26], hypertensive
etinopathy [32], light-induced retinal damage [27], and more.
herefore, we used ADR-induced retinal toxicity as an example for
nvestigating how DIO protects the retina.
In this study, we investigated the role and mechanism of DIO
ytoprotection in the retina. First, we demonstrated that this
avonoid from chrysanthemum could protect the retina from apo-
tosis via reducing DNA damage and oxidative stress. Moreover,
his ﬁnding favors DIO as a potential retinal-protective drug candi-
ate for alleviating the severity of eye diseases in the clinic, and it
an be developed as a complementary medicine.
. Materials and methods
.1. Drugs and chemicals
Diosmetin (purity: 99.0%) was purchased from Nanjing Zelang
edical Technology Company (Nanjing, China). Adriamycin was
 generous gift from Zhejiang Cancer Hospital (Hangzhou, China).
 stock solution of Adriamycin (50 mM)  and Diosmetin (50 mM)
as prepared with dimethyl sulfoxide (DMSO) and stored at
20 ◦C. The stock solution was further diluted with the appro-
riate assay medium immediately before use. The ﬁnal DMSO
oncentration did not exceed 0.2% throughout the study. Antibod-
es for procaspase-3, cleaved caspase-3, PARP, -action, Bcl-2 and
-H2AX were purchased from Santa Cruz Biotechnology (CA, USA).
econdary anti-mouse, anti-goat and anti-rabbit antibodies were
urchased from Santa Cruz Biotechnology (CA, USA). The western
lot detection reagent ECL was purchased from Pierce Biotech-
ology (Rockford, USA). The TUNEL cell apoptosis detection kit
as purchased from Beyotime Institute of Biotechnology (Haimen,
hina). The Annexin V FITC-Propidium Iodide (PI) kit was purchased
rom Sigma Chemical Co. (St. Louis, MO).
.2. Animal treatment and drug administration
Animal care procedures were approved by National Institute
f Health Guide for the Care and Use of Laboratory Animals and
ere in accordance with the Association for Research in Vision and
phthalmology Statement for the Use of Animals in Ophthalmic
nd Vision Research. Sprague–Dawley male rats (body weight of
90–220 g, 6 weeks old) were supplied by the Shanghai Labora-
ory Animal Center, Chinese Academy of Sciences and housed in a
lean grade room at 21 ± 1 ◦C and 60 ± 5% humidity under a 12-h
ight/dark cycle. Rats were fed sterile tap water and chow diet ad
ibitum from Shanghai SLAC Laboratory Animal Co., Ltd.
Three groups of rats (n = 8 in each group) received 5 l intrav-
treal injections in the right eye with ADR, DIO, or both, through
 Hamilton syringe with a 30-gauge needle into the inferotem-
oral part of the eye. The other eye was injected with the same
olume of vehicle (0.015% DMSO in saline, highest DMSO concen-
ration among drug groups) and served as a control. According
o the drug concentration in vitro, rats were treated with ADR
1.5 M/eye) and DIO (6 M/eye) through IVI 5 days before they
ere euthanized. The eyeballs were surgically excised and ﬁxed
n phosphate-buffered 10% formaldehyde. The ﬁxed eyes wereports 3 (2016) 78–86 79
sectioned at the pars plana area and the posterior segment was dis-
sected into tissue samples for microscopic observation or stored in
tissue protein extraction reagent for western blot analysis.
2.3. Histopathological analysis
Retina samples were ﬁxed in 10% phosphate-buffered formalin
and embedded in parafﬁn. Sections were stained with hematoxylin
and eosin (H&E) for histopathological analysis and the central parts
of the lesions were examined by light microscopy.
2.4. TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP nick end
labelling (TUNEL) assays were performed with a one-step TUNEL
kit according to the manufacturer’s instructions. Retina samples
were treated as mentioned in the histopathological analysis. Brieﬂy,
retina tissue sections were pretreated with proteinase K, washed
with PBS, and then stained by TUNEL reaction mixture (label and
enzyme solutions) for 1 h at 37 ◦C. The FITC-labelled TUNEL-positive
cells were imaged under a ﬂuorescent microscope (DMI 4000 B,
Leica, Germany) using 488 nm excitation and 530 nm emission. The
cells with green ﬂuorescence were deﬁned as apoptotic cells.
2.5. Western blot analysis
The protein samples of the dissected retina or ARPE-19 cells
were extracted in lysate buffer and the total protein concentration
of whole cell lysates was determined using the Bradford method
(BioRad, Hercules, CA, USA). 40.0–80.0 g of total proteins were
loaded per lane and fractionated on 10–15% Tris glycine precast
gels, transferred to PVDF membrane (Millipore, Bedford, MA), and
probed with primary antibodies and then HRP-labeled secondary
antibodies. Proteins were visualized using ECL.
2.6. Cell lines and cell culture
ARPE-19 cells (from ATCC cell line) were cultured in DMEM/F12
medium supplemented with 10% heat-inactivated foetal serum.
The cells were cultured at 37 ◦C in a humidiﬁed 5% CO2 atmosphere,
and the medium was  changed every other day.
2.7. Cytotoxicity assay
ARPE-19 cells were seeded in 96-well plates (3 × 104/well). After
treatment with varying concentrations of ADR (0–1.5 M) and DIO
(0–8.0 M),  viable cells were determined using an MTT  assay. MTT
was added (30.0 l/well), and plates were incubated for an addi-
tional 4 h at 37 ◦C. The purple formazan crystals were dissolved in
100 l of DMSO. After the crystal dissolved, the plates were read
on an automated microplate spectrophotometer (ThermoMulti-
skan Spectrum, Thermo Electron Corporation, USA) at 570 nm. The
concentration of drug inhibition for 50% of the cells (IC50) was  cal-
culated using the PrismPad computer program (GraphPad Software
Inc., USA) with Microcomputers.
2.8. Flow cytometry analysis of cell apoptosis
The Annexin V FITC-Propidium Iodide (PI) kit was used to detect
cell apoptosis. The cells were grown on a six-well plate at 1 × 105
cells/well and treated with drugs for 48 h at 37 ◦C. The cells were
washed twice and collected with PBS (137 mM NaCl, 2.7 mM KCl,
4.3 mM Na2HPO4, and 1.4 mM KH2PO4). Staining for apoptosis
was performed according to the manufacturer’s instructions. PI-
negative, Annexin V-negative staining cells are considered to be live
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ells, and PI-negative, Annexin V-positive staining cells are consid-
red to be early apoptotic cells. The stained cells were analyzed with
ACScan (BD Bioscience, San Jose, CA) using Cell-Quest software.
.9. DAPI staining assay
ARPE-19 cells were cultured in 24-well plates and treated with
rugs for indicated time. Washed the cells twice with PBS and
hen incubated with 4′,6-diamidino-2-phenylindole (DAPI) which
as diluted with 0.1% Triton X-100 for 5 min. Photographed the
hanges of nuclei with ﬂuorescence microscope (DMI 4000 B, Leica,
ermany).
.10. Measurement of intracellular ROS
The level of intracellular ROS was measured using the oxida-
ion sensitive ﬂuorescent dye H2DCFDA. An increase in the green
uorescence intensity was used to quantify the generation of intra-
ellular ROS. After H2DCFDA was added, at a ﬁnal concentration
f 10.0 M,  to the culture medium, the ARPE-19 cells in 24-well
lates were incubated at 37 ◦C for an additional of 30 min; then,
hey were harvested, washed with PBS, and measured immediately
y FACScan using an argon laser at 488 nm and a 525 nm bandpass
lter.
.11. Measurement of intracellular GSH
The ARPE-19 cells (1 × 106) treated with ADR (1.5 M)  and DIO
6 M)  for 12 h were harvested, sonicated intermittently 3 times
n ice. Then the cell lysates were spinned and the supernatants
ere collected. The content of intracellular GSH was  detected by
he enzymatic recycling method using glutathione reductase and
′,5′-dithio-bis (2-nitrobenzoic acid) (DTNB) in which GSH was
xidized by DTNB and reduced by NADPH in the presence of glu-
athione reductase. 2-Nitro-5-thiobenzoic acid (TNB) formation
as monitored by a spectrophotometer (ThermoMultiskan Spec-
rum, Thermo Electron Corporation, USA) at 405 nm.
.12. Assessment of the mitochondrial membrane potential ( m)
The ARPE-19 cells (1 × 106) were incubated with 10 g/ml JC-1
or 30 min  at 37 ◦C. JC-1 is a cationic dye that exhibits potential-
ependent accumulation in the mitochondria, which is indicated
y a ﬂuorescence emission shift from green (525 ± 10 nm)  to red
610 ± 10 nm). The samples (1 × 104 cells/sample) were observed
ith a ﬂuorescence microscope (DMI 4000 B, Leica, Germany).
itochondrial depolarization is speciﬁcally indicated by a decrease
n the red-to-green ﬂuorescence intensity ratio.
.13. Immunoﬂuorescence analysis
ARPE-19 cells after drug treatment were then ﬁxed with ice-
old methanol for 10 min. This step was followed by blocking with
% bovine serum albumin/PBS at 37 ◦C for 1 h. The coverslips were
hen incubated with -H2AX antibody (1:100 dilution) 37 ◦C for
 h, which were then washed with 2% bovine serum albumin/PBS
or 10 min  at room temperature and incubated with 1:500 dilution
f Alexa 488-(Ex:Em:499:519) conjugated secondary antibody. We
bserved the changes in the nuclei with a ﬂuorescence microscope
DMI 4000 B, Leica, Germany)..14. Statistical analysis
All experiments were repeated at least 3 times. The values from
uantitative experiments are expressed as the mean ± standardports 3 (2016) 78–86
deviation (SD) and were calculated using SAS. The Student’s t-
test and a two-way analysis of variance (ANOVA) were performed
to determine the differences between the control and treatment
groups. P < 0.05 were considered to be statistically signiﬁcant.
3. Results
3.1. DIO protects against ADR-induced retinal injury in vivo and
in vitro
To test the hypothesis that DIO is the key component of
chrysanthemum in improving retinal function, we investigated the
mechanism by which DIO protects the retina in vivo and in vitro
based on the ADR-treated toxic model.
To maintain the therapeutic level in eyes, intravitreal injection
(IVI), the clinical route of administration of ADR, was  applied in our
vivo model (Fig. 1A). Rats were intravitreally injected with ADR
and DIO, and the histological results of the retina 5 days after treat-
ment are presented in Fig. 1B. After a single injection of ADR at
a concentration of 1.5 M per eye, slices of retina exhibit atrophy
and degeneration of the pigment epithelium with detachment and
widespread apoptotic cells (Fig. 1B). These data offer gross support
for the ADR toxicity in retinal cells, especially RPE cells [19,32].
By contrast, the damage was  largely attenuated by DIO at a con-
centration of 6 M per eye (Fig. 1B). This observation supports the
hypothesis that DIO reverses the retinal damage.
Furthermore, we used ARPE-19 cells, a cell line derived from
human retinal pigment epithelium, to further explore the effect
and mechanism of DIO protection for the retina. We conﬁrmed
that cell proliferation was inhibited, in a concentration-dependent
manner, after ADR treatment, and the IC50 at 72 h was  0.84 M
(Fig. 1C). As expected, DIO treatment could signiﬁcantly decrease
the ADR inhibition effect even at a high concentration (Figs. 1D and
E). This in vitro model could be generalized to study the protective
mechanism of DIO in the retina.
3.2. DIO attenuates ADR-induced human retinal pigment
epithelium cell apoptosis
Recent reports have described RPE cell death through apoptotic
mechanisms associated with retinal diseases and pathophysiolog-
ical states [24,47]. In addition, the role of cell apoptosis in ADR
retinopathy has been analyzed [4,10]. To evaluate whether the
impact of DIO on RPE cell viability involves cell apoptosis, the sta-
tus of TUNEL-staining cells in the retinal tissue of Sprague–Dawley
rats was observed after drug treatment. In Fig. 2A, the number of
TUNEL-positive cells, in green ﬂuorescent color, increased with ADR
and was attenuated with DIO. Meanwhile, the cell nuclear mor-
phology was analyzed in vitro with DAPI staining after 72 h of drug
treatment. As shown in Fig. 2B, there was extensive nuclear conden-
sation and fragmentation from RPE cells treated with ADR, which
is an indicator of cell apoptosis. However, co-treatment with DIO
resulted in a decrease in nuclear abnormity.
To perform further quantitative analysis of RPE cell apoptosis,
we applied ﬂow cytometry combined with Annexin V/PI staining,
facilitating the apoptosis count. As shown in Fig. 2C, the right ﬁeld
(Annexin V-positive staining) shows the apoptotic cells [24]. Fig. 2C
shows a signiﬁcant increase in the apoptosis rate when the ARPE-
19 cells were exposed to 1.5 M ADR. Moreover, when the ARPE-19
cells were co-treated with 6 M DIO, the cell attenuation of apo-
ptosis was signiﬁcant.Additionally, caspase-3 denitrosylation facilitates its down-
stream target poly ADP-ribose polymerase (PARP) degradation,
which dominantly modulates the apoptosis pathway. As shown
in Fig. 2D and E, an increase in cleaved caspase-3 and PARP frag-
Z. Shen et al. / Toxicology Reports 3 (2016) 78–86 81
Fig. 1. DIO protects against ADR-induced retinal injury in vivo and in vitro.
(A)  The chemical structure and the intravitreal injection (IVI) route of DIO. (B) Slices of retina were stained with hematoxylin and eosin (H&E) for histopathological analysis.
Representative histomicrographs of retina sections of non-drug treament group, 6 M DIO treatment group, 1.5 M ADR treatment group and co-injected group. Arrows
indicate the thickness of the pigment epithelium layer. (C) Determination of the IC50 of ARPE-19 cells treated with ADR at increasing concentrations (0–1.5 M) for 72 h. The
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f  ADR for 72 h. The data represent the mean ± SD (n = 4), ***P < 0.001 (ADR vs. contr
1.5  M) and DIO (6 M)  treatment.
ents expression from ADR treatment, were blocked by treatment
ith DIO both in vivo and in vitro. All of these data revealed that
poptosis plays a vital role in the retinal protective effect of DIO.
.3. DIO prevents ADR-triggered DNA damage in RPE cells
DNA damage is a common cause of retinal diseases. Long-term
unlight exposure, especially UV irradiation, could signiﬁcantly
nduce DNA damage in the retina [27,40]. Known as a DNA poi-
on, ADR treatment can mimic  DNA damage in the retina, including
ausing a high number of double-strand breaks [2]. -H2AX is a sen-
itive indicator of double-strand DNA breaks produced by ionizing
adiation and drugs that cause double-strand breaks [29,39].
Based on our above observations that the growth arrest in RPE
ells was reversed by DIO, we next asked whether DIO could repair
he DNA damage in the retina. To this end, we microscopically
xamined the drug-treated cells for -H2AX foci that form around
he DNA breakage sites. Control cells lacked -H2AX foci, indicating
hat the breaks were induced by ADR exposure and abated by DIO
Fig. 3A and B). Corroborating this observation, western blot anal-
sis of drug-treated cell lysates also conﬁrmed the 24 h expression
f -H2AX in vivo and in vitro (Fig. 3C).
It is widely accepted that DNA damage is an early important
vent in cell apoptosis, where the activation and accumulation of
53 are prominent mediators [20,37]. It is possible that this effectte was measured with MTT  assays. Cells were treated with 6 M of DIO and 1.5 M
P < 0.001 (DIO + ADR vs. ADR). (E) Cell morphology was observed after 72 h of ADR
on DNA may  be related to the signalling events of growth arrest
and p53 activation. By western blot analysis, we  conﬁrmed the high
expression of p53, and inhibition by DIO treatment, in injured RPE
cells (Fig. 3C). The data show that DIO prevents ADR–triggered DNA
damage in RPE cells.
3.4. DIO inhibits ADR-induced oxidative stress and mitochondria
dysfunction in RPE cells
A growing body of clinical and experimental data strongly impli-
cate oxidative stress as a constant threat to the structural and
functional integrity of the retina [35]. The RPE monolayer is exposed
to high levels of visible light and oxygen under normal circum-
stances [6]; therefore, the RPE is at a risk for oxidative damage.
Excessive reactive oxygen species (ROS) in cells are known to
induce apoptosis, eventually leading to death [15].
Given that (i) the excessive ROS provides a major push to RPE
cells to undergo apoptosis [35] and (ii) the presence of phenolic
hydroxyl groups in DIO indicates it has potential antioxidant activ-
ity (Fig. 1A), we measured the changes in the relative ROS level in
cells. ARPE-19 cells were stained with H2DCFDA and analyzed by
ﬂow cytometry (Fig. 4). ADR-treated cells exhibited a signiﬁcant
increase in the mean ﬂuorescence compared to control (Fig. 4A).
The ROS level increased by ADR treatment at 3 h was  similar to that
induced by H2O2 (Fig. 4A). This result suggests the critical role of
82 Z. Shen et al. / Toxicology Reports 3 (2016) 78–86
Fig. 2. DIO attenuates the ADR-induced human retinal pigment epithelium cells apoptosis.
(A)  DIO reduced apoptosis in the RPE cells in vivo. The retinal tissues were terminal deoxynucleotidyl transferase-mediated dUTP nick end labelled and were imaged by
ﬂuorescent microscopy. The content of TUNEL-positive cells was equal to the number of green points in the photograph. Arrows indicate the thickness of the pigment
epithelium layer. (B–C) DIO reduced the apoptosis of RPE cells in vitro. (B) ARPE-19 cells were treated with ADR and DIO for 72 h, and nuclei changes were photographed
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fter  IVI, PARP and cleaved PARP expression were analyzed. (E) In vitro, ARPE-19 ce
o  evaluate the levels of caspase-3, PARP and their cleaved fragments.
OS in ADR-induced cell apoptosis, which is consists with other
eports in the literature [8,43].
Moreover, we evaluated the effect of DIO on the enhanced ROS
evel in cells. The data show that treatment with DIO resulted in
uch lower levels of ADR-induced intracellular production of ROS.he ARPE-19 cells. (D) In vivo, retina extracts were analyzed by western blot analysis
re treated with drugs for 48 h and whole cell lysates were analyzed by western blot
There were decreased ROS levels in the DIO + ADR group compared
with the ADR mono-treated group (Fig. 4B), indicating the retinal-
protective effect of DIO is mediated through inhibiting oxidative
damage.
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Fig. 3. DIO prevents ADR-triggered DNA damage in RPE cells.
(A)  Immunoﬂuorescent micrographs of control and drug-treated (24 h) cells stained for -H2AX foci (blue—nucleus; green—-H2AX foci). (B) Quantitation of the -H2AX
foci  in the micrographs from A. The data represent the mean ± SD (n = 4), ***P < 0.001 (ADR vs. control), ††P < 0.01 (DIO + ADR vs. ADR). (C) In vitro western blot analysis of p53
and  -H2AX expression in control and drug-treated (24 h) lysates. In vivo western blot analysis of -H2AX expression in control and drug-treated lysates.
Fig. 4. DIO inhibits ADR-induced oxidative stress.
(A) Flow cytometric evaluation of H2DCFDA stained-negative control, positive control and ADR-treated cells at various time points. (B) Effect of DIO on ADR (3 h) induced
ROS  in cultured RPE cells, as measured by ﬂow cytometry. (C) The content of intracellular GSH after treatment with ADR and DIO for 12 h. The data represent the mean ± SD
(n  = 4), *P < 0.05, **P < 0.01, ***P < 0.001 (ADR vs. control), ††P < 0.01 (DIO + ADR vs. ADR).
84 Z. Shen et al. / Toxicology Reports 3 (2016) 78–86
Fig. 5. DIO Inhibits ADR-induced mitochondria dysfunction in RPE cells.
(A) The effect of DIO on loss of the mitochondrial membrane potential in RPE cells. After treatment with DIO and ADR for 24 h at the indicated concentrations, a loss
in  the mitochondrial membrane potential was observed by microscopy after JC-1 staining. The green ﬂuorescence intensity indicated the cells with low mitochondrial
membrane potential, while the red ﬂuorescence intensity indicated the cells with stable mitochondrial membrane potential (n = 4). (B) Western blot analysis and corresponding
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.5  M ADR and 6 M DIO for 24 h and lysed; Bcl-2 was analyzed by western blot. 
s.  ADR).
Besides, GSH plays a crucial role in scavenging reactive oxygen
pecies [16], and alterations in GSH level can also be monitored as
n indication of oxidative stress in cells [49]. GSH depletion results
n impaired cell defence and tissue injury. ADR-induced oxidative
tress reduced the content of GSH, while elevation in GSH in DIO
reated cells suggest that it scavenges free radicals, generated dur-
ng oxidative stress (Fig. 4C).
The enriched mitochondrial population of the RPE exhibits
obust metabolic activity to meet the high-energy needs of these
ells. This process also increases local oxidative stress [35]. In turn,
xcessive oxidative stress can impair both short and long term
itochondrial function, reducing the energy production and result-
ng in loss of the mitochondrial membrane potential [11]. As loss
f the mitochondrial membrane potential is also one of the most
emarkable events in early apoptosis that leads to retinal damage,
C-1 staining was observed, and DIO preprocessing could antago-
ize the loss of mitochondrial membrane potential caused by ADR
Fig. 5A).
The mitochondrial apoptosis pathway is regulated by members
f the Bcl-2 protein family [5,12] and could be involved in some
ypes of retinal degeneration [42]. As a result, we also observed that
he anti-apoptotic protein Bcl-2, on the mitochondrial membrane,
as up-regulated in the DIO + ADR group compared to the ADR
roup (Fig. 5B). Altogether, these results further demonstrated that
IO protected the cells from mitochondrial-associated apoptosis.
. Discussion
Visual impairment is increasing as a global public health prob-
em and solutions for the impairment are still needed. In spite of
he progress made in surgical techniques in recent years, many
etinal diseases remain incurable. Classic ocular drugs consist of
nti-infective, anti-inﬂammatory and anti-allergic agents, such
s antibiotics, glucocorticoids and ETC. However, these drugs,
ith their similar effectiveness and side effects, are double-edged
words for patients. In addition, the progress of drug development
or eye diseases has been slow. At present, the most advanced androtein expression induced by ADR in cultured RPE cells. Cells were incubated with
ata represent the mean ± SD (n = 4), *P < 0.05 (ADR vs. control), †P < 0.05 (DIO + ADR
effective drugs are anti-VEGF biologics targeting neovasculariza-
tion. Although these costly anti-VEGF biologics are the standard of
care, they may  cause ocular or systemic side effects after IVI [9,45]
and are not always effective [28]. Therefore, drug development is
still needed.
Comparing to the drugs mentioned above, Chinese medicine is
rich in resources, more affordable, has few side effects, and there
is no drug resistance with long-term use. chrysanthemum is a tra-
ditional Chinese medicine for protecting vision. Numerous studies,
in ancient and modern China, have reported that chrysanthemum is
helpful in many eye diseases, including age-related macular degen-
eration (AMD), arteriosclerosis of the retina, diabetic retinopathy
and some drug-related retinal toxicities. However, few scientiﬁc
studies have focused on how chrysanthemum beneﬁts our eyes. To
the best of our knowledge, we  are the ﬁrst to identify the mecha-
nism of DIO, the component of chrysanthemum, action in protecting
vision and the possible signal pathways that are involved. As DIO
protects the RPE at every step of disease progression, as we expect,
it could be a promising, new, affordable drug with minimal side
effects to complement and perhaps be used in combination with
existing therapies.
The results presented in our study demonstrate the protective
effect of DIO on DNA damage and oxidative stress, preventing RPE
cells from apoptotic death in vivo and in vitro. As far as we know, the
RPE monolayer is at risk for oxidative damage [35] as in ADR treat-
ment. Excessive oxidative stress in RPE cells could induce apoptosis
[15], leading to several types of retinal diseases [14,26]. Recently,
antioxidant therapy has been applied to clinical retinal diseases
[17]. DIO is a powerful free radical scavenger that protects several
types of cells from oxidative damage [7,50]. In this study, insights
into the molecular mechanisms reveal that treatment with DIO
reverses the trend in ROS, GSH, the mitochondrial potential and
Bcl-2 expression caused by ADR, and we will focus on the relation-
ship among these manners in our further studies. We conﬁrmed
the anti-oxidative property of DIO in RPE cells, making it a useful
supplement in the therapy for these oxidative stress-related retinal
diseases.
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More importantly, our study also showed that DIO could prevent
NA damage in RPE cells. DNA strand damage is common in retinal
njury, especially UV irradiation [27,40]. DNA strand breaks activate
he expression of -H2AX, which could be triggered by ADR treat-
ent [2]. We  found that DIO could directly protect cells from DNA
njury. Recent studies have revealed that some ﬂavonoids, such as
uercetin and luteolin, can intercalate into DNA strands [44], and
IO has a similar structure. Therefore, we have reason to posit that
IO may  interact with the ADR–DNA–TOP2 complex as well [31].
e also found that DIO could downregulate the accumulation of
53 in an obvious manner, rescuing RPE cells from DNA damage,
his being a caspase-independent effect [48]. We  propose that DIO
ould interact with the DNA or p53 or both to protect the DNA, and
he mechanism requires further exploration. This is the ﬁrst report
f DIO and its ability to protect DNA. Meanwhile, this DNA protec-
ive effect should be expanded into a new method of preventing
NA damage-related retinal diseases.
In conclusion, this is the ﬁrst paper to identify a deﬁnite extract,
IO, from chrysanthemum, that possesses a retinal-protective effect
hrough restoring oxidative stress and DNA injury in the RPE layer.
he results strongly justify the role of DIO a potential retinal-
rotective drug candidate to alleviate the severity of eye diseases
n the clinic and provide evidence that it should be developed as a
omplementary medicine and undergo clinical evaluation.
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